lood products.                                                                                                                                
  Proton-pump inhibitor (IBP) therapy, domperidone and sucralfat.                                                                                                                 
  DAPT suspended.                                                                                                                                                                 
  Day 3                                                             Haematemesis in small quantity.                                                                               Therapeutic maintenance.
  Day 4                                                             Favourable evolution, with haemodynamic stabilization and without haematemesis.                               Therapeutic maintenance.
  Day 5                                                             Endoscopy showing resolution of the previously described lesions.                                             Oral diet was progressively initiated.
  Day 6                                                                                                                                                                           IBP was switched to oral formulation.
  Day 7                                                                                                                                                                           DAPT was re-instituted.
  Day 8                                                             Patient was discharged clinically well and without any symptoms.                                              
  August 2017                                                       Follow-up in outpatient clinic, without symptoms or complications.                                            

Case presentation
=================

We present the case of an 86-year-old woman with a past medical history of endometrial cancer, treated by hyst